Related Experiment Video

Updated: Oct 18, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Validating a decision support system for anti-epileptic drug treatment. Part II: adjusting anti-epileptic drug

R Smeets1, J Talmon, H Meinardi

  • 1Department of Medical Informatics, University of Maastricht, The Netherlands. raymond.smeets@mi.unimaas.nl

International Journal of Medical Informatics
|January 5, 2000
PubMed

More Related Videos

A Study on an Intelligent Diagnosis and Treatment Assistant System for Acupuncture in Diminished Ovarian Reserve Based on a Knowledge Graph08:43

A Study on an Intelligent Diagnosis and Treatment Assistant System for Acupuncture in Diminished Ovarian Reserve Based on a Knowledge Graph

Published on: May 29, 2026

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...